Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Apr 18, 2019 3:04pm
88 Views
Post# 29646276

RE:RE:Financials

RE:RE:Financials
Gustoes wrote:
harpos wrote: They were fine, smaller loss by over 40 percent. The big thing was that in the release, they reiterated the start is EARLY second quarter, also, the next two cancer indications are GBM and lung cancer.


I agree harpos. I'm finally pretty excited. That's why this patent is so important... gmb and lung will use rutherrin.

3 to 5 m in bank. Patent should be finalized soon. Phase II NIMB, Phase I gmb/lung announcements. Go on a nice run after the FOD-tards bash us down... .48 perhaps if they're lucky.. based on L2.. then off like a rocket to get frustys .54 warrants in the bank.

This will be exciting.


There we go,, crazytraders boiler room is at least using house 2, RBC. They had to fight hard for that and give up their own shares to do it,, FOD not working losers,,, longs own TLT.
Bullboard Posts